The G490E mutation in reverse transcriptase does not impact tRNA primer selection by HIV-1 with altered PBS and A-loop

Virology

Volumn 352, Issue 2, 2006, Pages 380-389

  Xu, Wenqin ^a   Morrow, Casey D ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

HIV 1; Primer binding site; Reverse transcriptase; tRNA

Indexed keywords

LYSINE; METHIONINE; PRIMER RNA; RNA DIRECTED DNA POLYMERASE; TRANSFER RNA;

ARTICLE; BINDING SITE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; LABORATORY; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; REVERSE TRANSCRIPTION; VIROGENESIS; VIRUS INFECTIVITY; VIRUS MUTATION; VIRUS REPLICATION;

AMINO ACID SUBSTITUTION; BASE SEQUENCE; BINDING SITES; CELL LINE; DNA, VIRAL; GENES, VIRAL; HIV-1; HIV-1 REVERSE TRANSCRIPTASE; HUMANS; MOLECULAR SEQUENCE DATA; POINT MUTATION; RNA; RNA, TRANSFER; TRANSFECTION; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 33747082882     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2006.04.019     Document Type: Article

References (28)

1. Abbink T.E.M., Beerens N., and Berkhout B. Forced selection of a human immunodeficiency virus type 1 that uses a non-self tRNA primer for reverse transcription: involvement of viral RNA sequences and the reverse transcriptase enzyme. J. Virol. 78 19 (2004) 10706-10714
2. Beerens N., and Berkhout B. Switching the in vitro tRNA usage of HIV-1 by simultaneous adaptation of the PBS and PAS. RNA 8 (2002) 357-369
3. Cen S., Javanbakht H., Kim S., Shiba K., Craven R.C., Rein A., Ewalt K.L., Schimmel P., Musier-Forsyth K., and Kleiman L. Retrovirus-specific packaging of aminoacyl-tRNA synthetases with cognate primer tRNAs. J. Virol. 76 (2002) 13111-13115
4. Lys,3. J. Virol. 69 5 (1995) 3090-3097
5. Derdeyn C.A., Decker J.M., Sfakianos J.N., Wu X., O'Brien W.A., Ratner L., Kappes J.C., Shaw G.M., and Hunter E. Sensitivity of human immunodeficiency virus type 1 to the fusion inhibitor T-20 modulated by coreceptor specificity defined by the V3 loop of gp120. J. Virol. 74 (2000) 8358-8367
6. Glu for replication. J. Virol. 77 16 (2003) 8756-8764
7. Javanbakht H., Halwani R., Cen S., Saadatmand J., Musier-Forsyth K., Gottlinger H., and Kleiman L. The interaction between HIV-1 Gag and human lysyl-tRNA synthetase during viral assembly. J. Biol. Chem. 278 30 (2003) 27644-27651
8. Jiang M., Mak J., Ladha A., Cohen E., Klein M., Rovinski B., and Kleiman L. Identification of tRNAs incorporated into wild-type and mutant human immunodeficiency virus type 1. J. Virol. 67 (1993) 3246-3253
9. Jiang M., Mak J., Huang Y., and Kleiman L. Reverse transcriptase is an important factor for the primer tRNA selection in HIV-1. Leukemia 8 Suppl. 1 (1994) S149-S151
10. Kang S.-M., and Morrow C.D. Genetic analysis of a unique human immunodeficiency virus type 1 (HIV-1) with a primer binding site complementary to tRNAMet supports a role for U5-PBS stem-loop RNA structures in initiation of HIV-1 reverse transcription. J. Virol. 73 (1999) 1818-1827
11. Kang S.M., Wakefield J.K., and Morrow C.D. Mutations in both the U5 region and the primer-binding site influence the selection of the tRNA used for the initiation of HIV-1 reverse transcription. Virology 222 (1996) 401-414
12. Kang S.-M., Zhang Z., and Morrow C.D. Identification of a sequence within U5 required for human immunodeficiency virus type 1 to stably maintain a primer binding site complementary to tRNAMet. J. Virol. 71 1 (1997) 207-217
13. Lys,3 for initiation of reverse transcription. Virology 257 (1999) 95-105
14. Phe expressed in human cells can be selected by HIV-1 for use as a reverse transcription primer. Virology 313 (2003) 354-363
15. Kelly N.J., Palmer M.T., and Morrow C.D. Selection of retroviral reverse transcription primer is coordinated with tRNA biogenesis. J. Virol. 77 (2003) 8695-8701
16. Lys,3 into HIV-1. J. Mol. Biol. 299 (2000) 17-26
17. Li X., Mak J., Arts E.J., Gu Z., Kleiman L., Wainberg M.A., and Parniak M.A. Effects of alterations of primer-binding site sequences on human immunodeficiency virus type 1 replication. J. Virol. 68 10 (1994) 6198-6206
18. Lys into human immunodeficiency virus type 1 particles. J. Virol. 68 (1994) 2065-2072
19. gag-pol incorporation into HIV-1. J. Mol. Biol. 265 (1997) 419-431
20. Marquet R., Isel C., Ehresmann C., and Ehresmann B. tRNAs as primer of reverse transcriptases. Biochimie 77 (1995) 113-124
21. Moore-Rigdon K.L., Kosloff B.R., Kirkman R.L., and Morrow C.D. Preferences for the selection of unique tRNA primers revealed from analysis of HIV-1 replication in peripheral blood mononuclear cells. Retrovirology 2 21 (2005)
22. Panet A., and Berliner H. Binding of tRNA to reverse transcriptase of RNA tumor viruses. J. Virol. 26 (1978) 214-220
23. Peters G., and Dahlberg J.E. RNA-directed DNA synthesis in Moloney murine leukemia virus: Interaction between the primer tRNA and the genome RNA. J. Virol. 31 (1979) 398-407
24. Temin H.M. Structure, variation and synthesis of retrovirus long terminal repeat. Cell 27 (1981) 1-3
25. Lys,3. J. Virol. 69 (1995) 6021-6029
26. His. J. Virol. 70 (1996) 966-975
27. His. Virology 226 (1996) 306-317
28. Zhang Z., Kang S.-M., Li Y., and Morrow C.D. Genetic analysis of the U5-PBS of a novel HIV-1 reveals multiple interactions between the tRNA and RNA genome required for initiation of reverse transcription. RNA 4 (1998) 394-406